Source虎嗅•Stalecollected in 6m
Ex-GE CEO Urges Founder Mindset for China Localization
#medtech-localization#china-ai-rd#foreign-strategyge-healthcarege-medicaldeepseekdanaher
💡AI localization pitfalls for foreign medtech: approvals slow innovation
⚡ 30-Second TL;DR
What Changed
Localize full R&D chain and IP in China for speed and autonomy.
Why It Matters
Foreign AI/medtech firms risk lagging without bold localization; accelerates China as global AI innovation source.
What To Do Next
Assess HQ approval flows for local AI model experiments like DeepSeek in your medtech pipeline.
Who should care:Enterprise & Security Teams
Key Points
- •Localize full R&D chain and IP in China for speed and autonomy.
- •AI R&D hurdles: DeepSeek vs. foreign models, complex global approvals.
- •Shift from growth engine to innovation hub; embrace long-termism.
- •Trust local talent with decision rights for core SQDCI metrics.
📰
Weekly AI Recap
Read this week's curated digest of top AI events →
👉Related Updates
AI-curated news aggregator. All content rights belong to original publishers.
Original source: 虎嗅 ↗
This is a summary, not the original. Read the source, or get the weekly briefing.
The weekly digest
One email a week. Unsubscribe anytime.